Buys
Open market- Shares
- Avg price
- Total value
Gregory R. Friberg - EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- EVP, Chief R&D Officer
- Issuer Symbol
- BMRN on Nasdaq
- All Insider Reports
- All Insider Reports
Gregory R. Friberg - trading volume in the past year for BIOMARIN PHARMACEUTICAL INC
Sells
Open market- Shares
- -9,607
- Avg price
- $58.15
- Total value
- -$558,619
Net
Past year- Shares
- -9,607
- Share %
- -100%
- Total value
- -$558,619
Holdings reported by Gregory R. Friberg for BIOMARIN PHARMACEUTICAL INC
Form 4 holding
EVP, Chief R&D Officer
BIOMARIN PHARMACEUTICAL INC
- Security class
- Common Stock
- Shares / value
- 51,818
- Estimated value
- $2,790,399
- Report date
- 07 May 2026
- Price
- $53.85
- Ownership
- Direct
Form 4 holding
EVP, Chief R&D Officer
BIOMARIN PHARMACEUTICAL INC
- Security class
- Stock Option (Right to Buy Common Stock)
- Shares / value
- 45,600
- Estimated value
- Report date
- 16 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Gregory R. Friberg for BIOMARIN PHARMACEUTICAL INC
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.